804 related articles for article (PubMed ID: 20448470)
41. New Pertussis Vaccines: A Need and a Challenge.
Hozbor D
Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
[TBL] [Abstract][Full Text] [Related]
42. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
Bouchez V; Guiso N
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
[TBL] [Abstract][Full Text] [Related]
43. Pertussis: acellular, whole-cell, new vaccines, what to choose?
Locht C
Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372
[No Abstract] [Full Text] [Related]
44. The pertussis enigma: reconciling epidemiology, immunology and evolution.
Domenech de Cellès M; Magpantay FM; King AA; Rohani P
Proc Biol Sci; 2016 Jan; 283(1822):. PubMed ID: 26763701
[TBL] [Abstract][Full Text] [Related]
45. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
46. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity and protective potential of Bordetella pertussis biofilm and its associated antigens in a murine model.
Dorji D; Graham RM; Singh AK; Ramsay JP; Price P; Lee S
Cell Immunol; 2019 Mar; 337():42-47. PubMed ID: 30770093
[TBL] [Abstract][Full Text] [Related]
48. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
[TBL] [Abstract][Full Text] [Related]
49. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
[TBL] [Abstract][Full Text] [Related]
50. Development and Validation of a
da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A
J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598
[TBL] [Abstract][Full Text] [Related]
51. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():51. PubMed ID: 29416544
[TBL] [Abstract][Full Text] [Related]
52. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
Gillard J; van Schuppen E; Diavatopoulos DA
Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
[TBL] [Abstract][Full Text] [Related]
53. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM
Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453
[TBL] [Abstract][Full Text] [Related]
54. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
55. [Recent epidemiology of pertussis: implications for vaccination].
Levy J
Rev Med Brux; 2014 Sep; 35(4):330-4. PubMed ID: 25675639
[TBL] [Abstract][Full Text] [Related]
56. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
Front Immunol; 2022; 13():838504. PubMed ID: 35211125
[TBL] [Abstract][Full Text] [Related]
57. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.
Mooi FR; van Loo IH; van Gent M; He Q; Bart MJ; Heuvelman KJ; de Greeff SC; Diavatopoulos D; Teunis P; Nagelkerke N; Mertsola J
Emerg Infect Dis; 2009 Aug; 15(8):1206-13. PubMed ID: 19751581
[TBL] [Abstract][Full Text] [Related]
58. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
Moraga-Llop FA; Campins-Martí M
Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
[TBL] [Abstract][Full Text] [Related]
59. Editorial: Pertussis: current problems, challenges and investigations of a re-emerging disease.
Carbonetti N
Pathog Dis; 2015 Nov; 73(8):ftv090. PubMed ID: 26490977
[No Abstract] [Full Text] [Related]
60. Bordetella pertussis and pertussis vaccines.
Guiso N
Clin Infect Dis; 2009 Nov; 49(10):1565-9. PubMed ID: 19839747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
